Suchergebnisse - "Breccia, Massimo"

PubPharm (59)

1

Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia : A study from the Registro Italiano LMC and Campus CML

enthalten in: Cancer | 2023

von Tiribelli, M. | Latagliata, R. | Breccia, M. | +38

2

The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines : Findings from a Real-World Analysis in Italy

enthalten in: Advances in therapy | 2023

von Breccia, M. | Chiodi, F. | Nardozza, A. | +8

3

The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines: Findings from a Real-World Analysis in Italy

enthalten in: Advances in therapy | 2022

von Breccia, M. | Chiodi, F. | Nardozza, A. | +8

4

The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines: Findings from a Real-World Analysis in Italy

enthalten in: Advances in therapy | 2022

von Breccia, M. | Chiodi, F. | Nardozza, A. | +8

5

The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines: Findings from a Real-World Analysis in Italy

enthalten in: Advances in therapy | 2022

von Breccia, M. | Chiodi, F. | Nardozza, A. | +8

6

A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase

enthalten in: Journal of hematology & oncology | 2022

von García-Gutiérrez, V. | Breccia, M. | Jabbour, E. | +2

7

Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials : a real-life cohort observational study

enthalten in: Acta oncologica (Stockholm, Sweden) | 2021

von Stagno, F. | Breccia, M. | Annunziata, M. | +24

8

Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the GIMEMA CML observational study

enthalten in: Leukemia | 2021

von Breccia, M. | Pregno, P. | Castagnetti, F. | +13

9

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

enthalten in: Annals of hematology | 2021

von Scalzulli, E. | Caocci, G. | Efficace, F. | +12

10

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

enthalten in: Annals of hematology | 2021

von Scalzulli, E. | Caocci, G. | Efficace, F. | +12

1
2
3
4
5
6
Nächster »
[6]